Healthcare - Biotechnology - NASDAQ - CA
$ 39.61
-7.78 %
$ 241 M
Market Cap
-62.87
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--
EBIT
Estimate
--
Net Income
Estimate
--
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bright Minds Biosciences Inc.
DRUG has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart DRUG
DRUG has no estimates for Revenue Forecast.
EBIT FORECAST
EBIT Forecast Chart DRUG
DRUG has no estimates for EBIT Forecast.
NET INCOME FORECAST
Net Income Chart DRUG
DRUG has no estimates for Net Income.